Vladimir Lerner

2.3k total citations
95 papers, 1.6k citations indexed

About

Vladimir Lerner is a scholar working on Psychiatry and Mental health, Neurology and Clinical Psychology. According to data from OpenAlex, Vladimir Lerner has authored 95 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 24 papers in Neurology and 19 papers in Clinical Psychology. Recurrent topics in Vladimir Lerner's work include Schizophrenia research and treatment (22 papers), Electroconvulsive Therapy Studies (11 papers) and Bipolar Disorder and Treatment (10 papers). Vladimir Lerner is often cited by papers focused on Schizophrenia research and treatment (22 papers), Electroconvulsive Therapy Studies (11 papers) and Bipolar Disorder and Treatment (10 papers). Vladimir Lerner collaborates with scholars based in Israel, Russia and United States. Vladimir Lerner's co-authors include Chanoch Miodownik, Joseph Bergman, Eliezer Witztum, Michael S. Ritsner, Moshe Kotler, Tzvi Dwolatzky, Yuly Bersudsky, Anatoly Kreinin, Anatoly Gibel and Uri Loewenthal and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Vladimir Lerner

92 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimir Lerner Israel 23 658 473 214 190 190 95 1.6k
Yuly Bersudsky Israel 27 916 1.4× 117 0.2× 154 0.7× 317 1.7× 201 1.1× 89 1.8k
Toshihito Suzuki Japan 27 438 0.7× 193 0.4× 232 1.1× 463 2.4× 303 1.6× 96 1.9k
Joseph F. Lipinski United States 25 874 1.3× 238 0.5× 360 1.7× 337 1.8× 104 0.5× 43 1.7k
Jun Ishigooka Japan 24 757 1.2× 116 0.2× 167 0.8× 196 1.0× 164 0.9× 123 1.6k
Jurjen J. Luykx Netherlands 26 726 1.1× 125 0.3× 384 1.8× 190 1.0× 253 1.3× 138 1.9k
Kevin E. Stanford United States 23 990 1.5× 100 0.2× 378 1.8× 134 0.7× 105 0.6× 30 2.1k
Krishna Vaddadi Australia 23 473 0.7× 272 0.6× 156 0.7× 377 2.0× 250 1.3× 42 1.7k
Takaaki Mori Japan 22 614 0.9× 182 0.4× 125 0.6× 168 0.9× 76 0.4× 81 1.5k
C. G. Gottfries Sweden 23 508 0.8× 134 0.3× 81 0.4× 228 1.2× 101 0.5× 48 1.5k
Suzanne Reeves United Kingdom 26 708 1.1× 232 0.5× 185 0.9× 319 1.7× 112 0.6× 81 1.9k

Countries citing papers authored by Vladimir Lerner

Since Specialization
Citations

This map shows the geographic impact of Vladimir Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Lerner more than expected).

Fields of papers citing papers by Vladimir Lerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Lerner. The network helps show where Vladimir Lerner may publish in the future.

Co-authorship network of co-authors of Vladimir Lerner

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Lerner. A scholar is included among the top collaborators of Vladimir Lerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Lerner. Vladimir Lerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miodownik, Chanoch, et al.. (2019). Clinical and demographic characteristics of secluded and mechanically restrained mentally ill patients: a retrospective study. Israel Journal of Health Policy Research. 8(1). 9–9. 15 indexed citations
2.
Lerner, Vladimir, Peter McCaffery, & Michael S. Ritsner. (2016). Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date. CNS Drugs. 30(4). 269–280. 14 indexed citations
3.
Kreinin, Anatoly, et al.. (2016). Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine. Journal of Clinical Psychopharmacology. 36(3). 200–205. 13 indexed citations
4.
Bersudsky, Yuly, et al.. (2015). A pilot open study of long term high dose creatine augmentation in patients with treatment resistant negative symptoms schizophrenia.. PubMed. 52(1). 6–10. 5 indexed citations
5.
Miodownik, Chanoch, et al.. (2015). Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder. Clinical Neuropharmacology. 38(1). 26–29. 6 indexed citations
6.
Bergman, Joseph, et al.. (2013). Curcumin as an Add-On to Antidepressive Treatment. Clinical Neuropharmacology. 36(3). 73–77. 68 indexed citations
7.
Ritsner, Michael S., et al.. (2010). Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder. The Journal of Clinical Psychiatry. 71(10). 1351–1362. 76 indexed citations
8.
Ritsner, Michael S., et al.. (2010). L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder. The Journal of Clinical Psychiatry. 72(1). 34–42. 57 indexed citations
9.
Kreinin, Anatoly, et al.. (2009). Moclobemide Treatment of Clozapine-Induced Hypersalivation. Clinical Neuropharmacology. 32(3). 151–153. 10 indexed citations
10.
Lerner, Vladimir, et al.. (2008). The influence of immigration on the mental health of those seeking psychiatric care in southern Israel: a comparison of new immigrants to veteran residents.. PubMed. 45(4). 291–8. 3 indexed citations
11.
Miodownik, Chanoch, et al.. (2007). Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients. The Journal of Clinical Psychiatry. 68(7). 1031–1037. 42 indexed citations
12.
Miodownik, Chanoch, et al.. (2006). Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia. Clinical Neuropharmacology. 29(2). 68–72. 32 indexed citations
13.
Miodownik, Chanoch & Vladimir Lerner. (2006). Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Review of Neurotherapeutics. 6(7). 983–992. 8 indexed citations
14.
Lerner, Vladimir, et al.. (2005). Quetiapine-Associated Depression in a Patient With Schizophrenia. Clinical Neuropharmacology. 28(3). 133–135. 5 indexed citations
15.
Lerner, Vladimir, et al.. (2005). Augmentation With Amisulpride for Schizophrenic Patients Nonresponsive to Antipsychotic Monotherapy. Clinical Neuropharmacology. 28(2). 66–71. 21 indexed citations
16.
Lerner, Vladimir, et al.. (2005). Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clinical Nutrition. 25(1). 60–67. 40 indexed citations
17.
Lerner, Vladimir, et al.. (2003). Combination of “atypical” antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 89–98. 59 indexed citations
18.
Lerner, Vladimir, Chanoch Miodownik, Hagit Cohen, et al.. (2001). Vitamin B6 in the Treatment of Tardive Dyskinesia: A Double-Blind, Placebo-Controlled, Crossover Study. American Journal of Psychiatry. 158(9). 1511–1514. 53 indexed citations
19.
Dorevitch, A, et al.. (1997). Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia. International Clinical Psychopharmacology. 12(3). 171–174. 9 indexed citations
20.
Lerner, Vladimir, et al.. (1995). Maintenance Medication for Schizophrenia and Schizoaffective Patients. Schizophrenia Bulletin. 21(4). 693–701. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuly Bersudsky Breakdown of academic impact, for papers by Toshihito Suzuki Breakdown of academic impact, for papers by Joseph F. Lipinski Breakdown of academic impact, for papers by Jun Ishigooka Breakdown of academic impact, for papers by Jurjen J. Luykx Breakdown of academic impact, for papers by Kevin E. Stanford Breakdown of academic impact, for papers by Krishna Vaddadi Breakdown of academic impact, for papers by Takaaki Mori Breakdown of academic impact, for papers by C. G. Gottfries Breakdown of academic impact, for papers by Suzanne Reeves
Rankless by CCL
2026